Article
Three vascular endothelial growth factor polymorphisms (-460C>T, -2578C>A, 1612G>A) with cancer risk: a meta-analysis based on 30 case-control studies.
Cancer investigation - 1 Aug 2011
Hong Ting-Ting, Cai Dong-Yan, Wu Xiao-Hong, Hua Dong
Abstract excerpt
We evaluated cancer risk with three VEGF polymorphisms (-460C>T, -2578C>A, 1612G>A) based on current available studies. -460C>T did not appear to influence cancer risks. -2578C carriers had a 30% reduction of colorectal cancer (CRC) risk in comparison with AA homozygote (OR: 0.70, CI: 0.56-0.88). 1612G carriers had a striking 84% reduction of gastric cancer risk in comparison with AA homozygote. Multiple...
Topics
- Case-Control Studies
- Genotype
- Humans
- Neoplasms
- Polymorphism, Genetic
- Risk
- Vascular Endothelial Growth Factor A
